Chemiesynth (Vapi) reported a net loss of Rs 0.99 crore for FY 2025-26, compared to a Rs 0.11 crore loss in the previous year. While revenue grew to Rs 21.45 crore, rising labor and operational expenses pressured margins. To address liquidity, the company plans a Rs 15 crore private placement of non-convertible preference shares and a significant hike in authorized share capital.
Chemiesynth (Vapi) Reports Widened Annual Loss of Rs 0.99 Crore
Company Plans Rs 15 Crore Preference Share Raise to Boost Liquidity
Reader Takeaway: Revenue growth is currently offset by rising operational expenses, prompting a liquidity-focused capital infusion plan.
What just happened
Chemiesynth (Vapi) Limited has released its Annual Report for FY 2025-26, highlighting a period of financial strain. The company recorded a net loss of Rs 0.99 crore, a significant increase from the Rs 0.11 crore loss reported in the prior fiscal year. Despite this, gross income saw an uptick, rising to Rs 21.45 crore from Rs 18.90 crore.
Why this matters
The widening bottom-line deficit reflects the company's struggle with escalating operational costs. Management explicitly cited higher labor charges and increased spending on effluent disposal as the primary contributors to the profitability decline. This filing also sets the stage for a major corporate action: the board has proposed raising Rs 15 crore through a private placement of 5% Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) to bridge funding gaps.
What changes now
Shareholders will vote on key corporate actions at the upcoming 40th Annual General Meeting scheduled for September 30, 2026. The proposed hike in authorized share capital from Rs 3.25 crore to Rs 18.25 crore is a precursor to the preference share issuance. These shares are set for redemption after seven years, with internal provisions for call and put options after two years.
Governance and Leadership
The firm has undergone a leadership transition following the death of former CFO Parimal A. Desai in September 2025. Suresh Lad was subsequently appointed as the new CFO in December 2025. Additionally, director Rushabh Mehta is up for reappointment following his retirement by rotation.
What to track next
Investors should focus on how the infusion of Rs 15 crore is deployed across working capital and debt refinancing. Furthermore, the company’s ability to manage its effluent disposal costs and enforce stricter credit controls will be critical to returning the company to a path of operational profitability.